Occidental Eyes Major Permian Basin Expansion With Potential $10B CrownRock Acquisition: Report

Occidental Petroleum Corporation (NYSE: OXY) is reportedly planning to buy CrownRock, a significant energy producer in the

Occidental Petroleum Corporation (NYSE:OXY) is reportedly planning to buy CrownRock, a significant energy producer in the western Texas area of the Permian basin.

Negotiations for the privately owned firm, potentially worth over $10 billion in debt, may soon conclude, provided discussions remain intact, and no competing bidders emerge, according to a news report by The Wall Street Journal. 

Related: Oil Majors: Are BP And Chevron Attractively Valued After Share Price Tumbles?

CrownRock, led by Texas billionaire Timothy Dunn and supported by private-equity firm Lime Rock Partners, holds over 80,000 net acres in Texas’ Midland Basin, a section of the Permian Basin, the top oil-producing area in the U.S, the report read.

As one of the few large private entities left in the Permian, alongside Endeavor Energy Resources, CrownRock stands out. 

Under Dunn’s leadership, the company secured leases in the region before the shale boom. 

Through strategic trades and land swaps, Dunn established CrownRock’s current prominent position in a highly sought-after area of the basin.

Occidental, with a market value of approximately $53 billion, last made a significant acquisition in 2019 when it bought Anadarko for $38 billion. This deal burdened the company with substantial debt and drew the attention of activist investor Carl Icahn.

Read Next: Phillips 66 Embraces Elliott’s Turnaround Vision, Eyes ‘Constructive Dialogue’ for Major Stock Boost

Price Action: OXY shares are trading higher by 0.66% to $60.73 premarket on the last check Thursday.  

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Photo Via Company

Total
0
Shares
Related Posts
Read More

Studies Led By Harvard Pilgrim Health Care Institute, HCA Healthcare And The University Of California, Irvine Announce Two Clinical Trials Identified A Better Way To Target Appropriate Antibiotics For Patients Hospitalized With Pneumonia Or Urinary Tra…

Algorithm driven alerts help identify best antibiotic for patients with common infections in two 59-hospital trials, with implications to reduce antibiotic resistanceTwo large multi-state studies uncovered a highly

HCA